• AcouSort received a EUR 9,500 project order from MFX to evaluate acoustic cell washing at higher flow rates.
• The study extends an AcouWash lease agreement initiated in Q1 2026, focusing on cell isolation from lysed blood.
• Testing will assess whether larger sample volumes can be processed to meet full-scale production throughput requirements.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AcouSort AB published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.